WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KURA

Based on 4 analysts offering 12 month price targets for Kura Oncology Inc.
Min Forecast
$26.00+47.06%
Avg Forecast
$31.75+79.58%
Max Forecast
$37.00+109.28%

Should I buy or sell KURA stock?

Based on 4 analysts offering ratings for Kura Oncology Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KURA stock forecasts and price targets.

KURA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-01-31
lockedlocked$00.00+00.00%2023-12-22

1 of 1

Forecast return on equity

Is KURA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is KURA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

KURA revenue forecast

What is KURA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$192.1M
Avg 2 year Forecast
$18.9M
Avg 3 year Forecast
$169.1M

KURA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KURA$17.68$31.75+79.58%Strong Buy
RCUS$14.84$38.60+160.11%Strong Buy
GYRE$15.41N/AN/A
DAWN$15.75$38.25+142.86%Strong Buy
MORF$27.51$56.00+103.56%Strong Buy
View Top Biotech Stocks

Kura Oncology Stock Forecast FAQ

Is Kura Oncology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: KURA) stock is to Strong Buy KURA stock.

Out of 4 analysts, 1 (25%) are recommending KURA as a Strong Buy, 3 (75%) are recommending KURA as a Buy, 0 (0%) are recommending KURA as a Hold, 0 (0%) are recommending KURA as a Sell, and 0 (0%) are recommending KURA as a Strong Sell.

If you're new to stock investing, here's how to buy Kura Oncology stock.

What is KURA's revenue growth forecast for 2024-2026?

(NASDAQ: KURA) Kura Oncology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Kura Oncology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast KURA's revenue for 2024 to be $14,625,910,592, with the lowest KURA revenue forecast at $14,625,910,592, and the highest KURA revenue forecast at $14,625,910,592. On average, 3 Wall Street analysts forecast KURA's revenue for 2025 to be $1,441,501,120, with the lowest KURA revenue forecast at $304,547,852, and the highest KURA revenue forecast at $3,212,979,839.

In 2026, KURA is forecast to generate $12,874,379,758 in revenue, with the lowest revenue forecast at $738,528,541 and the highest revenue forecast at $34,352,997,706.

What is KURA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KURA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is KURA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year KURA price target, the average KURA price target is $31.75, with the highest KURA stock price forecast at $37.00 and the lowest KURA stock price forecast at $26.00.

On average, Wall Street analysts predict that Kura Oncology's share price could reach $31.75 by Mar 6, 2025. The average Kura Oncology stock price prediction forecasts a potential upside of 79.58% from the current KURA share price of $17.68.

What is KURA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KURA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.